Patients With HVAD System At Risk, Warns FDA
The agency does not recommend elective removal of the device
The US Food and Drug Administration is advising health care providers that patients with the Medtronic Heartware Ventricular Assist Device (HVAD) System are at risk from potential device malfunction.
You may also be interested in...
A welding defect may allow moisture to enter affected heart pumps, which can lead to device failure, the US FDA explained. Medtronic first announced the recall in April.
The company had issued two recalls in the past few months for the device due to recorded deaths and adverse events, but after further analyses has decided to pull it off the market altogether.
The US Food and Drug Administration is alerting health care providers that some cardiac devices from a major supplier are in short supply.